Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.41Debt to Equity Ratio
VS
Market
Sector
Industry
History
$ 1.36Close
$ 1.34 - $ 49.92 52-Week Range
Ticker Information
Ticker
REVBCompany Name
REVELATION BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQREVELATION BIOSCIENCES INC - Debt to Equity Ratio Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
REVB - D/E Historical data
| Date | Debt to Equity Ratio | Shareholders Equity | Total Liabilities |
|---|---|---|---|
| 6/30/2025 | 0.41 | $ 3.83M | $ 1.57M |
| 3/31/2025 | 0.38 | $ 2.88M | $ 1.09M |
| 12/31/2024 | 0.41 | $ 4.71M | $ 1.91M |
| 9/30/2024 | 1.52 | $ 2.67M | $ 4.07M |
| 6/30/2024 | 9.76 | $ 1.14M | $ 11.13M |
| 3/31/2024 | 0.55 | $ 9.47M | $ 5.23M |
| 12/31/2023 | 0.84 | $ 6.65M | $ 5.56M |
| 9/30/2023 | 0.61 | $ 8.82M | $ 5.4M |
| 6/30/2023 | 0.41 | $ 11.41M | $ 4.62M |
| 3/31/2023 | 0.81 | $ 10.02M | $ 8.1M |
Key Performance Insights, Last 5 Years
- REVELATION BIOSCIENCES INC's latest trailing twelve months (TTM) D/E stands at 272.09.
- Over the past 5 years, REVELATION BIOSCIENCES INC's average D/E has been 21.04.
- The median D/E for REVELATION BIOSCIENCES INC during this period was 0.71
- REVELATION BIOSCIENCES INC reached its highest D/E over the past 5 years at 272.09.
- The lowest D/E recorded by REVELATION BIOSCIENCES INC in the same timeframe 0.38
Similar metrics to Liabilities:
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Free Cash Flow to Debt - [Calculation] The Free Cash Flow to Debt ratio allows investors to judge a company’s financial stability. It represents the fraction of debt that could be repaid within one year if all of the free cash flow would be used to repay debt. It is calculated by dividing Free Cash Flow [FCF] by a company’s [Liabilities].
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
Definition of Debt to Equity Ratio
[Calculation] Debt to Equity (D/E) measures the ratio between a company’s [Liabilities] and [Equity]. A high ratio might indicate more risk.Liabilities / Equity
(=) D/E D/E for REVELATION BIOSCIENCES INC is calculated as follows: Liabilities [ $ 3.49M ] / Equity [ $ 12.81K ]
(=) D/E [ 272.09 ] REVB - Debt to Equity Ratio, Last 5 years
0.38
Minimum
Mar 31, 2025
272.09
Maximum
Sep 30, 2020
21.04
Average
0.71
Median
D/E Benchmark AnalysisMarket
The chart above depicts the distribution of D/E for companies in the Total Stock Market. The average D/E of the companies is 1.4 with a standard deviation of 1.31.
The following table provides additional summary stats:
D/E in the Market:
| filtered constituents | 3.3K |
|---|---|
| min | 0 |
| max | 6.06 |
| average | 1.4 |
| median | 0.98 |
| std | 1.31 |